Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial

Eur J Heart Fail. 2007 Feb;9(2):110-2. doi: 10.1016/j.ejheart.2007.01.004. Epub 2007 Jan 30.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Erythropoietin / biosynthesis*
  • Erythropoietin / therapeutic use
  • Heart Failure / drug therapy*
  • Humans
  • Randomized Controlled Trials as Topic / methods*
  • Treatment Outcome*

Substances

  • Erythropoietin